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ABSTRACT: The 2019-2020 SARS-related coronavirus-2 (SARS-CoV-2) pandemic has brought unprecedented
challenges to healthcare sectors around the world. As of November 2020, there have been over 64 million confirmed
cases and approaching 2 million deaths globally. Despite the large number of positive cases, there are very limited
established standards of care and therapeutic options available. To date, there is still no Food and Drug
Administration (FDA) approved vaccine for COVID-19, although there are several options in various clinical trial
stages. Herein, we have performed a global review evaluating the roles of age and sex on COVID-19 hospitalizations,
ICU admissions, deaths in hospitals, and deaths in nursing homes. We have identified a trend in which elderly and
male patients are significantly affected by adverse outcomes. There is evidence suggesting that sex hormone levels
can influence immune system function against SARS-CoV-2 infection, thus reducing the adverse effects of COVID19. Since older adults have lower levels of these sex hormones, we therefore speculate, within rational scientific
context, that sex steroids, such as estrogen and progesterone, needs further consideration for use as alternative
therapeutic option for treating COVID-19 elderly patients. To our knowledge, this is the first comprehensive article
evaluating the significance of sex hormones in COVID-19 outcomes in older adults.
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1. Introduction
Amidst the SARS-related coronavirus-2 (SARS-CoV-2)
pandemic, it is important to investigate vulnerable
populations and possible treatment options. Despite
public health campaigns to encourage social distancing,

quarantining, hygiene practices, and wearing face masks,
the number of cases of Coronavirus Disease 2019
(COVID-19) has yet to decline [1-3]. The virus was first
identified in Wuhan, Hubei, People’s Republic of China
in December 2019 when cases of unexplained pneumonia
and acute respiratory distress syndrome (ARDS) were
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linked to an open-air seafood wholesale market. Scientists
have proposed that the virus is transmitted to humans from
the reservoir bats through different hosts [4]. By January
2020, the virus was only spreading within Wuhan; but
since then, near global spread has occurred resulting in the
World Health Organization (WHO) declaring a
‘pandemic’ on March 11th, 2020 [5].
The geriatric population is particularly vulnerable to
suffering severe symptoms and mortality due to preexisting comorbidities and diminished immunity [6, 7].
New data have revealed that men are at greater risk of
suffering severe symptoms and mortality compared to
women. According to information gathered from Global
Health 50/50.org, the populations more likely to suffer
severe symptoms exist at the intersection of old age and
being male. There is speculation that the effect of sex
steroid hormones may modestly contribute to this
disparity of increased intensive care unit (ICU)
admissions between men and women. Additionally, the
natural waning of hormone production over the course of
one’s lifetime can similarly account for the increased risk
of death in the elderly population [8]. The correlation
between sex hormones, disease severity, and death rates
reveals the potential of utilizing hormone replacement
therapy (HRT) to modulate the immune response to
increase resilience to adverse disease outcomes [9, 10].

Nursing homes are well-documented settings for
acquisition of nosocomial infection. Transmission of the
SARS-CoV-2 virus through droplets makes it difficult to
properly quarantine patients residing in these healthcare
facilities [11]. Because COVID-19 has proven to be fatal
particularly in the elderly population, it is necessary to
consider possible agents that can minimize the bodily
inflammatory responses that may lead to death. As
previously stated, men are more likely than women to
develop severe symptoms. One advantage that women
have is higher levels of estrogen and progesterone, which
has been shown to modulate a more robust immune
response [12-15]. In order to decrease the incidence of
infection and disease severity of COVID-19, HRT may be
proposed as a method of boosting immunity of individuals
who are most at risk. HRT has been used to alleviate
symptoms of menopause and aging in both men and
women, respectively. Currently there are two clinical
studies investigating the effectiveness of estrogen and
progesterone therapy to decrease disease severity of
COVID-19 (Table 1). Overall, we propose that the clinical
application of sex hormone therapy might be a viable
alternative for the treatment of the adverse inflammatory
effects of COVID-19 in older adults, especially males, as
they are the most affected of both sexes.

Table 1. COVID-19 Clinical Trials Using Hormone Replacement Therapy (HRT).
Clinical Trial
Estrogen Patch for
COVID-19
Symptoms
Clinical Trial
Identifier:
NCT04359329
Progesterone for
the Treatment of
COVID-19 in
Hospitalized Men
Clinical Trial
Identifier:
NCT04365127

Description

Intervention

Phase

Status

Eligibility

The use of an estrogen patch
for 7 days could reduce the
severity of COVID-19
symptoms. Determined by
the rate of hospitalization,
transfer to ICU, intubation,
and death over 30 days.
The administration of
progesterone to determine
the safety and efficacy in
hospitalized COVID-19
positive males. Determined
by the clinical status of
subject at Day 15 and Day
29 and the duration of
supplemental oxygen.

Estradiol
Patch.
100g/day
for
7 days

2

Recruiting

Progesterone
100MG.
Injected
twice daily
for 5 days

1

Active,
but not
recruiting

18+ males, 55+
female, COVID-19+,
1+ of the following
symptoms;
fever>100.5, SOB,
cough, pneumonia+
x-ray
18+ males, COVID19+, Respiratory
symptoms,
Abnormal lung
exam, Abnormal xray, ↓ O2saturation

2. SARS-CoV-2: Structure, mechanism of infection,
and COVID-19 symptoms
SARS-CoV-2 is an enveloped, positive sense, single
stranded RNA virus that is ~30 kb in length [4]. It is a
member of the genus Betacoronavirus and the subgenus
Sarbecovirus. Its genome codes for 4 structural proteins,
one of which is the Spike (S) glycoprotein. S proteins are
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Participant
#
110

40

responsible for attracting and facilitating binding with
human Angiotensin Converting Enzyme 2 (ACE-2)
receptors, found in human respiratory epithelium and lung
parenchyma, thus aiding viral entry [4]. ACE-2 is a key
component to vasodilation via the Renin-AngiotensinAldosterone-System (RAAS) and is upregulated in
commonly used pharmacotherapies for managing blood
pressure. Because binding of the viral S protein to ACE-2
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may increase the risk of infection, ACE inhibitors have
been suggested as a possible therapy for COVID-19.
Interestingly, it was recently reported that sex steroids can
skew ACE-2 expression in human airway; therefore, it is
plausible to believe that there is a relationship between the
levels of endogenous sex hormones, ACE-2 expression,
and the severity of SARS-CoV-2 infection. SARS-CoV-2
is the 7th virus of the family Coronaviridae
(Coronaviruses) known to infect humans; four of them
being typical causes of the common cold [16]. The SARSCoV-2 virus is most similar to the Severe Acute
Respiratory Syndrome Coronavirus (SARS-CoV), which
caused the SARS pandemic from 2002-2003 [14].
In a study analyzing the viral genomic sequences of
SARS-CoV and SARS-CoV-2, scientists noted a 79%
similarity on a nucleotide level between them in the S

Global sex disparity of COVID-19

protein region segment 601-640, including the D614
position [17]. Mutations of the viral genome have resulted
in the emergence of distinct clades, whose variation may
influence global disparities in infection rates. The initial
outbreak in Wuhan was of Clade O, but the current
dominant strain is thought to be the A2a variant. Unique
mutations have been noted in studies conducted in several
countries [18]. In terms of mutations in the A2a variant
clade, a defining difference was observed in SARS-CoV2 S protein aspartic acid D614 resulting in a shift to
glycine, creating a D614G mutation [17]. Other mutations
have also been noted to contribute to SARS-CoV-2 global
diversity. For example, the P323L mutation of RNAdependent RNA polymerase is hypothesized to be
conserved during viral replication [18].

Figure 1. Global mortality and sexual disparity of COVID-19 by continents. (A) Global COVID-19 cases by sex
and continent (B) Pie chart representation of the percentage of COVID-19 cases by sex. (C) Global mortality rate of
COVID-19 deaths by sex and continent. (D) Pie chart representation of COVID-19 death percentages by sex. Male data
is represented in blue, while female data is represented by pink. Overall, data suggests that males have an increased risk
for COVID-19 infection and death, when compared to female counterparts. Data was generated from Global Health
5050.org, on the 16th of November 2020.

Human infection with SARS-CoV-2 is asymptomatic
in many that are infected, aiding its ability to circulate
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undetected. In patients with severe disease acuity, the
most common complications include pneumonia,
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respiratory failure, sepsis, cardiac injury, arrhythmia,
kidney injury, metabolic acidosis, or hypoxic
encephalopathy [19]. These complications can worsen the
symptoms of COVID-19 and might also be the reason for
high death rates in older adults.
3. COVID-19 global mortality rate and sex disparity
From the infancy of the COVID-19 pandemic, researchers
worldwide observed a disparity of morbidity and
mortality between men and women. Data suggest that men
who contract the virus tend to have more severe symptoms
compared to women, potentially inflating their death rate.
This may be explained by differences in sex steroid levels
which can alter the immune response, thus leading to a
disparity in disease burden [13]. Although infection rates
amongst men and women are marginal, men have a higher
death rate than women by 18.3%, with men accounting for
59.15% of total deaths (Fig. 1). One proposed explanation
is smoking, which is a habit more prevalent in men than
in women [20]. SARS-CoV-2 is spread through and
primarily affects the respiratory system, putting those who
smoke at higher risk for severe complications. Smoking
could exacerbate underlying conditions that would

Global sex disparity of COVID-19

worsen symptoms and prognosis of COVID-19. This risk
factor adversely affects outcomes in men.
Outbreaks of similar coronaviruses, SARS and
MERS, provide a foundation from which researchers can
reference. One SARS study that focused on the role of sex
hormones on infection and mortality in mice
demonstrated that male mice were highly susceptible to
the infection despite being exposed to the same viral load.
Male mice also experienced 90% mortality compared to
20% in female mice [12]. Researchers then compared
gonadectomized mice to their counterparts after infection.
The gonadectomized males did not show any difference
in mortality or morbidity rate, but gonadectomized
females had a significant increase in deaths [12]. These
results suggest that testosterone may not play a role in
infection or death rates; however, estrogen can influence
both infection rates and disease severity.
The afore-mentioned researchers also studied the
relationship of age on SARS mortality rates. They
concluded that the young age group was most resistant to
infection, and all mice in the oldest group died [12]. The
CDC has published that the average age of patients who
progressed to ARDS was 61 years old, and those who
were spared were on average 49 years old [21].

Figure 2. Sex-dependent effects on COVID-19 hospitalizations and ICU admission by select
countries. (A) COVID-19 related hospitalizations; and (B) ICU admissions, by sex. Men and
women are depicted by blue and pink datapoints, respectively. These charts reveal the overall male
preponderance in COVID-19 hospitalization and ICU admission, with Norway exhibiting the
largest sex-dependent predilection. The selected countries were chosen because they have publicly
available data for hospitalizations and ICU admissions. Data was generated from Global Health
5050.org, on the 16th of November 2020.
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4. COVID-19-related
admissions by sex

Global sex disparity of COVID-19

hospitalizations

and

ICU

Hospitalization and ICU admission rates by sex have
recently become available for 10 countries: Canada,
Chile, Denmark, France, Israel, New Zealand, Norway,
Scotland, Spain, USA (Fig. 2). In these countries, males
account for more than half of hospitalizations and ICU
admissions. The largest sex difference observed occurred
in Norway, with 60% of males being hospitalized and
74% of males in the ICU. This trend brings into
perspective the sex disparity in how males and females
respond to COVID-19. Further analysis of data set reveals
that, though both sexes are susceptible to SARS-CoV-2
infection in the geriatric population, males are more likely
to be admitted to the ICU (Fig. 2B).

5. Prevalence of COVID-19-related deaths in nursing
homes
Nursing homes are long-term care facilities that provide
health care services to people who are not eligible for
hospital admission but cannot be cared for at home.
Between 2015 and 2016, American adults aged 65 years
and older made up about 83.5% of the total nursing home
patient population [22]. Infection in nursing home care
facilities, especially among older adults, is a longstanding
healthcare challenge. In the current COVID-19 infection
pandemic, nursing homes have been severely hit with
disproportionately higher rates of mortality than the
general population (Fig. 3).

Figure 3. Total number of deaths in nursing homes linked to COVID-19. The United States has the highest
rates of COVID-19 deaths in general. Overall, New Zealand saw a much lower total number of cases but
observed the highest mortality rate within nursing homes when comparing deaths in nursing homes to total
COVID-19 deaths. This figure highlights the relationship of COVID-19 related deaths (y-axis) from hospitals
(blue bar graphs) to that of nursing homes (yellow bar graphs). The grey circles represent the percentage of
nursing home deaths to the overall mortality rates linked to COVID-19. Countries are defined alphabetically
along the x-axis.

As of October 21st, 2020, international data from 22
countries reveal that 46-47% of the total mortality rate
among nursing home residents is attributable to COVID19 related deaths [23]. For this analysis, COVID-19
related death was defined as follows: i) death of a person
who tests positive, before or after death, ii) death of a
person who was clinically or epidemiologically suspected
to have COVID-19, and iii) excess deaths when
compared to the deaths that occurred in the same week for
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the previous year [23]. The countries with the highest
number of home care residents’ COVID-19 deaths as a
percentage of all COVID-19 deaths include Slovenia
(81.2%), Canada (79.5%), and Australia (75.4%). Jordan
and South Korea had less than 10% of COVID-related
deaths in nursing homes [23].
It is important to consider that most of the nursing
home residents affected by COVID-19 had common
chronic underlying conditions including hypertension,
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cardiac disease, renal disease, diabetes, obesity, and
pulmonary disease [24]. In terms of preventive measures
against COVID-19 in nursing homes, the WHO published
an interim COVID-19 prevention and control guidance
for long-term care facilities on the 21st of March 2020
[25]. The main objective of the guideline is to prevent
increases in new cases as well as horizontal spread of
COVID-19 within and outside of nursing home facilities.
Similarly, the CDC also developed a COVID-19 Infection
Control Assessment and Response (ICAR) tool to help
nursing homes and other long-term care facilities assess
their infection prevention preparedness and quality
improvement so that lapses identified can be specifically
addressed [26].
6. Considerations for clinical and therapeutic use of
sex steroid hormones
The three major sex steroid hormones are estrogen,
progesterone, and testosterone. The hypothalamuspituitary-gonadal
(HPG)
axis
regulates
the
neuroendocrine feedback loop that facilitates
steroidogenesis. These hormones are synthesized
endogenously but their levels vary by sex and decrease
with older age. Sex hormones play crucial regulatory roles
in the process of human development and directly have an
impact on human behavior, anatomy, and physiology.
Testosterone is the dominant hormone in males and
estrogen/progesterone are the dominant hormones in
females. Both males and females go through a decrease in
sex hormone production with age, but the rate at which
the level of sex hormones decreases depends on the
individual. As the female body undergoes menopause, the
natural cessation of menses, the level of sex hormones in
the body dramatically decreases compared to the male
body, which tapers off slowly over time [27, 28]. Factors
such as obesity and chronic liver disease can also affect
the concentration of estrogen amongst individuals [28].
Exogenous HRT can replenish the low levels or loss
of sex hormones in an individual. For example, HRT is
common among post-menopausal women to mitigate
symptoms of menopause, such as hot flashes, night
sweats, mood swings, and vaginal atrophy [28]. Both
males and females experience a weakening of bones, a
condition known as osteoporosis, which can also be
countered therapeutically using hormone replacement
therapy [28, 29]. Testosterone replacement is often
supplemented in men through a topical gel [27], but is also
provided orally in pill form, or administered via
intramuscular injection. Estrogen is administered to
females as estradiol, a potent form of estrogen, which
comes in different forms such as pills, patches, topical
creams and suppositories [28]. Progesterone is usually
taken as a pill alongside estrogen because it can reduce the
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risk of some cancers and is available in other formulations
such as progestin IUD or progestin dermal implant [28].
Though sex steroids are useful for hormone-balance
restoration in post-menopausal adult females and aged
adult males, several groups of scientists have reported on
additional interesting therapeutic benefits of sex steroid
hormones including their roles in alleviating disease
burden due to viral infections [10].
HRT has been associated with therapeutic benefits in
improving
patient
outcomes
in
osteoporosis,
cardiovascular disease, muscle mass, physical strength,
and viral infections [8]. Potential risk factors of estrogen
replacement therapy are breast and endometrial cancer
[30]. However, there is no increased risk of developing
cancer until after 15-20 years on estrogen replacement
therapy (ERT) [30]. Trials were performed to further
understand the risk and to evaluate ways to prevent
malignancy; scientists concluded that using estrogen
concurrently with progesterone can prevent osteoporosis
without the increased risk of endometrial cancer but may
increase risk for ischemic heart disease [30]. Although
progesterone alone can have a preventative effect against
endometrial cancer, its use should be carefully monitored
because long term use of progesterone has been linked
with the development of breast cancer [31].
In summary, HRT can be beneficial for both male and
female geriatric patients who experience a natural
decrease in sex hormone production. Not only does HRT
mitigate undesirable side effects of aging such as
decreased sex drive, hot flashes, and fatigue, but it can
also reduce the risk of bone fractures and cardiac events.
The focus of this review, however, is to assess the use of
HRT to decrease disease burden in the geriatric
population from SARS-CoV-2 virus infection. Such
clinical trials investigating the efficacy of HRT for SARSCoV-2 are short-term, thus cancer risk in women may be
negligible if patients are being treated in the duration of a
pandemic.
7. HRT to modulate immune response against SARSCoV-2 infection
The two layering of the immunologic defense
mechanisms of the body are the innate and adaptive
subsystems [32]. The innate immunity is the first line of
defense against SARS-CoV-2 infection. The main cellular
components of the innate immune system include
dendritic cells, monocytes, macrophages, granulocytes,
and natural killer T cells [32]. However, when the acute
response of the innate immunity is incapable of
neutralizing and eliminating the invading virus, the
adaptive immune system is mobilized to assist in
combating the viral infection. The adaptive immune
system is slow but specific, consisting of B and T cells
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[32, 33]. The adaptive immune system is known to
respond to infections by using antigen receptor genes to
recognize invading pathogenic antigens [32]. Researchers
are investigating the crosstalk between sex hormones and
the immune system regulation with the rationale that sex
hormones can influence the immune system against
SARS-CoV-2 infection. For example, elevated estrogen
concentration and/or estrogen receptor alpha (ERα)
activation have been shown to enhance type I and III
interferon (IFN) synthesis, leading to a resultant decrease
in virus titer [34].
After a viral infection, an increased number and
activation of immune cells including lymphocytes,
myeloid cells, neutrophil leukocytes, monocytes, alveolar
macrophages, and dendritic cells are observed in
circulation [34]. Clinical and biomedical studies have
reported that sex hormones can influence the function of
immune cells against viral infections through binding to
specific receptors expressed in circulating macrophages,
dendritic cells, lymphocytes, and in various lymphoid
tissues [34-36]. Upon binding of hormones to the
receptors on immune cells, a cascade of signaling
pathways including c-Jun, NF-κB, and interferon
regulatory factor (IRF) 1 are influenced, resulting in
varying levels of cytokine and pro-inflammatory
responses [34]. Activated ERα has been shown to inhibit
NF-kB mediated inflammatory response and cytokine
production through regulation of cells of the immune

Global sex disparity of COVID-19

system including lymphocytes, macrophages, and
neutrophils [37].
Cytokine storm and excessive inflammation are two
major physiological events associated with SARS-CoV-2
viral infection [38-40]. The cytokine storm is usually
associated with an inflammatory response to viral
infections, triggering an increase in pro-inflammatory
cytokine levels [41]. At normal physiological levels, sex
steroid hormones, especially estrogen, have been reported
to possess an anti-inflammatory effect, but this effect was
seen only in pre-menopausal women [42-44]. However, it
has been reported that though post-menopausal women
have higher levels of pro-inflammatory cytokines, such as
interleukin (IL)-6 and IL-1 (major cytokines involved in
SARS-CoV-2 inflammatory process), the use of estrogenassociated hormone replacement therapy can decrease the
levels of these cytokines to pre-menopausal levels [44].
Testosterone, the major male sex steroid hormone, have
also been reported to efficiently downregulate
inflammation through the increase of anti-inflammatory
cytokines (IL-10) and the decrease of pro-inflammatory
cytokines (IL-1β, IL-6, and TNF-α) [45, 46]. These
studies suggest that sex hormones are viable candidates
for consideration in the development of therapeutics
against SARS-CoV-2 viral infection.

Figure 4. COVID-19 related deaths by age and sex in the top nine most affected countries: (A) USA (B) Italy (C) Peru (D)
Philippines (E) France (F) Mexico (G) Bangladesh (H) Australia (I) South Africa. In all cases, there is a trend confirming that
older adults experienced the highest death tolls from COVID-19. Additionally, in all cases herein, male patients exhibited higher
mortality rates. In an effort to represent the global COVID-19 incidence and death rates, in each continent, we selected the highestranking country with publicly available data. It is worth noting that in Australia, France, and Italy, adults over the age of 80,
especially males (B & E), were significantly more impacted when compared to additional age groups in the other countries. Male
data is represented in blue, while female data is represented by pink. Data was generated from Global Health 5050.org, on the 16th
of November 2020.
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8. Effects of aging, sex, and associated changes in
immune system components
The delicate balance between the innate and adaptive
immune systems in response to pathogenic infections can
be altered as age increases [47]. Not only does aging
promote the chronic activation of the innate immune
system and facilitates the decline of adaptive immune
functions, it also causes a natural decline in sex hormone
production [48-50]. Therefore, it is expected that females
and males would differ in their susceptibility and response
to SARS-CoV-2 infection, potentially explaining the
obvious disparity in incidence, severity, and mortality
rate. The activity of innate immune cells like macrophages
and dendritic cells inducing inflammatory responses are
generally higher post viral infection in females than in
males, as demonstrated in several animal studies [51-53].
It is therefore plausible to conclude that the nature of
immune response to SARS-CoV-2 infection can be
altered by supplementing endogenous sex steroid
hormones at various physiological stages, such as before
and after menopause, during pregnancy, and during
hormone replacement therapy [54]. The changes in
immune components have been observed to show a
bimodal sex hormone decline by age distribution. The first
time point occurs in both men and women around 40 years
of age, and the second time point occurs in men around
the early/mid 60’s and women around the late 60’s [47].
In China, it was observed that there was a doubling in
COVID-19 death rate in individuals around 40 years old
from 0.2% to 0.4% (www.worldometers.info/ coronavirus
/coronavirus-age-sex-demographics/). A second wave of
declining immunity occurs in individuals around 60 years
which coincides with an increase in severity and lethality
of COVID-19. This pattern is evident in the death rates
reported in different countries of the world (Fig. 4).
Interestingly, Italy, France, and Australia (Fig. 4B, 4E,
and 4H, respectively) have responded to the pandemic
effectively enough that the population ages 40-60 years
are well protected. This is evident from the lower agedependent incidence of COVID-19 cases. Worth noting,
the mortality rate in males in Italy (Fig. 4B) and France
(Fig. 4E) were significantly higher than males in other
countries.
A recent study of 244 older COVID-19 patients
reported that age and decreased lymphocyte count were
independently associated with hospital mortality [55].
Another recent study has shown evidence that the timing
of age-related changes in the immune system differ
between men and women [56]. The authors reported that
aging-related changes in both men and women included a
decline in adaptive immunity, and an activation of innate
immunity. These changes of increased inflammatory
events were reported to be more devastating in men.
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According to their data, peripheral blood B lymphocytes
were lower in older men aged 65+ years. This result
corresponds with clinical study data generated from
separate cohorts in France [56] and Japan [57]. Therefore,
these lines of evidence suggest that sex-related changes in
immunity can be altered by sex and with increase in age.
Presently, sex steroid hormones are among the list of
potential therapies being considered for preventing and
improving symptoms of COVID-19 disease. However,
there is currently no published study evaluating the effect
of HRT intervention for the different stages of COVID-19
in patients [58]. Hence, more biomedical and clinical
translational studies are needed to better understand the
pharmacological effects of exogenous hormone
replacement dosing and duration that can alleviate
COVID-19 incidence in patients.
9. Sex hormone therapy to prevent COVID-19
infection in the geriatric population
There is still a paucity of therapeutic options for treating
COVID-19. Additionally, there are insufficient number of
testing sites in many countries around the world,
particularly in underdeveloped countries. Currently,
physicians may only offer supportive care to patients who
have severe symptoms and require hospitalization. In the
most severe cases, remdesivir, a nucleoside analog, may
be administered to patients [59]. Remdesivir is an antiviral
drug that functions to inhibit the viral genome replication
of SARS-CoV-2 [60]. While we are optimistic that
remdesivir will have minimal long-term side effects, we
also believe that exploring other potential alternatives for
COVID-19 treatment would be in the best interest of the
citizens of the world. We now know that sex hormones
have other biological functions including antiviral effects.
Therefore, it is rational to consider sex steroid hormones
as potential treatment option in alleviating COVID-19
inflammatory and cytokine storm events, thereby
improving quality of life for geriatric individuals,
especially male counterparts.
9.1. Androgen (Testosterone)
It has been reported that androgen receptor activity is a
requirement for the transcription of the transmembrane
protease, serine 2 (TMPRSS2) gene [46, 61, 62], a cell
surface protein that is expressed by epithelial cells of
specific tissues including those in the aerodigestive tract
[61]. Also, there is existing evidence that TMPRSS2
activity is necessary for the activation of the SARS-CoV2 spike protein, viral entry, and spread in an infected host
[61, 62]. Of note, SARS-CoV, the virus responsible for
the 2003 SARS outbreak, H1N1 influenza, and the virus
responsible for the 1918 and 2009 influenza pandemics,
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depend on TMPRSS2 for viral activation and cell entry
[63-65]. These studies have a unifying conclusion that the
upregulation of TMPRSS2 by androgen receptor activity
could be the reason for the increased male predominance
in deaths from COVID-19. Surprisingly, we have come to
realize that this is not the universally accepted belief in the
research field, many researchers maintain differing
opinions.
A recent report has evidence that testosterone
supplementation can reduce COVID-19 cytokine storm
effect; thereby, suppressing SARS-CoV-2 induced
inflammation [46]. In SARS-CoV-2 pneumonia patients,
lower total testosterone (TT) was found in patients
transferred to the ICU or deceased in the respiratory
intensive care units (RICU) compared to patients
transferred to internal medicine units or maintained in the
RICU in stable condition [62]. Another group conducted
a retrospective study where the investigators
systematically analyzed sex hormones as well as cytokine
and chemokine responses in male and female patients
with laboratory-confirmed SARS-CoV-2 infections. They
reported that a significant number of male COVID-19
patients had low testosterone (68.6%) and low
dihydrotestosterone (48.6%) levels [66]. Though these
studies were conducted in SARS-CoV-2 infected patients,
we still believe that more studies are needed to validate
the antiviral effect of testosterone. Presently, there are ongoing COVID-19 clinical trials experimenting with
progesterone and estrogen but there is yet to be a clinical
trial investigating the use of testosterone therapy in
COVID-19 patients.
9.2. Progesterone
Compared to estrogen and testosterone, there are fewer
studies investigating the therapeutic potential of
progesterone in reducing the disease burden of COVID19 patients, particularly in older adults. Progesterone
deserves more research for its possible antiviral effect
against SARS-CoV-2 as there is existing evidence that
progesterone has antiviral effects against HIV [67] and
against influenza virus A [63]. Progesterone has also been
reported to reduce inflammatory events at mucosal sites,
like the respiratory tracts post-viral infection [68]. In
2010, a study reported that there was an observable
decrease in progesterone levels in SARS patients
compared to healthy controls. This implies that
progesterone signaling pathway might be involved in
antiviral immune response.
More recently, a study published in Nature reports
that progesterone has an anti-SARS-CoV-2 effect [69].
Another group reported that, in their study, four out of
eight pregnant women infected with SARS-CoV-2 were
asymptomatic before delivery but became symptomatic
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post-partum [70] further suggesting that progesterone
could be protective against SARS-CoV-2 infection. This
finding further strengthens the case that progesterone,
which is elevated during pregnancy and abruptly drops
upon delivery, might have potent anti-viral properties.
Furthermore, another recent study has also reported that
progesterone, in addition to estrogen and testosterone, has
anti-SARS-CoV-2 effect notably in older adults [71].
Presently, there is an ongoing clinical trial
[NCT04365127] that seeks to investigate the safety and
efficacy of progesterone for treatment of COVID-19 in
hospitalized men (Table 1). The findings from this clinical
trial will strengthen or weaken the existing evidence that
progesterone has antiviral activity against SARS-CoV-2.
9.3. Estrogen
Estrogen is the most studied sex steroid hormone because
of its many therapeutic uses, especially in combating viral
infections. Estrogen (17β-estradiol) has been reported to
have antiviral effects against viruses including influenza
virus [72], hepatitis C virus [73], SARS [74], and SARSCoV-2 [13, 71]. Estrogen and its immunomodulating
effects against SARS-CoV-2 infection is presently under
active investigation in different laboratories around the
world. Very recently, estrogen was shown to possess antiSARS-CoV-2 effect which occurs through the
suppression of TMPRSS2 expression in different cell
lines [13]. The antiviral effect of estrogen is due, in part,
to the many antiviral genes or inflammatory genes that
have estrogen response elements (EREs) in their promoter
regions which enhances estrogen-mediated cellular
signaling [13].
In 2013, Hilliard et al. reported that estrogeninduced expression of ACE-2 is reduced in
postmenopausal women [75]. This study, again, brings to
the forefront a relevant clue why elderly women are likely
less susceptible to SARS-CoV-2 infection than elderly
men. According to Suba et al, Premarin, can have gene
repairing power like endogenous estrogen without risk of
adverse reactions [14]. Premarin is a conjugated equine
estrogen derived from natural sources and has been
reported to have proven antiviral efficacy [14]. Presently,
there is an ongoing clinical trial [NCT04359329] that
seeks to investigate if estrogen, given as a patch placed on
the skin of COVID-19 patients including older adults can
reduce the severity of COVID-19 symptoms compared to
regular care (Table 1). Again, the findings from this
clinical trial will strengthen or weaken the existing
evidence that estrogen has antiviral activity against
SARS-CoV-2.
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10. Conclusion

Acknowledgements

The global burden of COVID-19 is taking a toll on
financial, economic, and healthcare sectors of many
countries around the world. This comprehensive review
seeks to report, using a biomedical and clinical knowledge
base, on one of the controversial topics that is worth
further investigation at this critical time. Sex hormones
are produced endogenously; therefore, they are not
harmful to the body or possess adverse effects if their
normal levels are maintained. However, the signaling
pathways or events related to gene transcription might be
altered leading to modified levels of these hormones
which might then pose some physiological consequences.
Here, we have summarized the perspectives of several
endocrine, aging, and immunology scientists on the
subject matter of sex hormones and how they regulate
immune function against SARS-CoV-2 infection.
Here we have gathered and analyzed data sets that are
available to the public to investigate the prevalence of
COVID-19 related cases and deaths by continents. We
then repeated the same process for COVID-19 related
hospitalizations and ICU admissions in top countries with
high COVID-19 prevalence. Finally, we analyzed death
rates by sex and age to further strengthen our hypothesis
that men are globally more affected by COVID-19
infection than women. Herein, we have summarized the
main highlights and conclusions of relevant scientific and
clinical studies published on sex hormone functions in
immunity, aging, and against SARS-CoV-2 infection.
There are now multiple sources of evidence that show
how sex hormones can be used as viable candidates for
consideration as potential antiviral prophylaxis. However,
it should be noted that HRT could have some side effects
such as breast and endometrial cancer in women.
In conclusion, compared to women, men are at higher
risk of SARS-CoV-2 infection, ICU admission,
hospitalization, and death rate in countries around the
world. This disparity in COVID-19 pandemic is most
likely
multifaceted
(biological,
lifestyle,
and
comorbidities, etc.) but sex hormone levels are arguably
one of the primary reasons why men and women respond
differently to SARS-CoV-2 infection. As the virus
continues to evolve and spread, there is an urgent need for
more treatment options and therapeutic modalities that
will be aimed at neutralizing SARS-CoV-2 infection and
improving symptoms of the COVID-19 disease.
Therefore, we recommend that the use of sex hormone as
possible therapy for COVID-19 older adults be given
maximum consideration as this clinical intervention might
help reduce the global disease burden of COVID-19.
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